Immunopathology and dexamethasone therapy in a new model for malaria-associated acute respiratory distress syndrome

Autor: Van Damme Jo, Heremans Hubertine, Verhenne Sebastien, Van Aelst Ilse, Deroost Katrien, Geurts Nathalie, Van den Steen Philippe E, Opdenakker Ghislain

Publikováno v: Malaria Journal, Vol 9, Iss Suppl 2, p I13 (2010)

Externí odkaz: https://doaj.org/article/00f7510d34604a1abebecc7057c233de

von Willebrand factor in experimental malaria‐associated acute respiratory distress syndrome

Autor: Kraisin, Sirima, Verhenne, Sebastien, Pham, Thao‐Thy, Martinod, Kimberly, Tersteeg, Claudia, Vandeputte, Nele, Deckmyn, Hans, Vanhoorelbeke, Karen, Van den Steen, Philippe E., De Meyer, Simon F. ^*

Publikováno v: In Journal of Thrombosis and Haemostasis August 2019 17(8):1372-1383

Platelet-derived VWF is not essential for normal thrombosis and hemostasis but fosters ischemic stroke injury in mice

Autor: Verhenne, Sebastien, Denorme, Frederik, Libbrecht, Sarah, Vandenbulcke, Aline, Pareyn, Inge, Deckmyn, Hans, Lambrecht, Antoon, Nieswandt, Bernhard, Kleinschnitz, Christoph, Vanhoorelbeke, Karen, De Meyer, Simon F. ^*

Publikováno v: In Blood 1 October 2015 126(14):1715-1722

Single‐domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors

Autor: Barbon, Elena, Ayme, Gabriel, Mohamadi, Amel, Ottavi, Jean-François, Kawecki, Charlotte, Casari, Caterina, Verhenne, Sebastien, Marmier, Solenne, Van Wittenberghe, Laetitia, Charles, Severine, Collaud, Fanny, Denis, Cecile, Christophe, Olivier, Mingozzi, Federico, Lenting, Peter

Publikováno v: EMBO Molecular Medicine
EMBO Molecular Medicine, Wiley Open Access, 2020, 12 (4), pp.e11298. ⟨10.15252/emmm.201911298⟩
EMBO Molecular Medicine, 2020, 12 (4), pp.e11298. ⟨10.15252/emmm.201911298⟩
EMBO Molecular Medicine, Vol 12, Iss 4, Pp n/a-n/a (2020)

Novel therapies for hemophilia, including non‐factor replacement and in vivo gene therapy, are showing promising results in the clinic, including for patients having a history of inhibitor development. Here, we propose a novel therapeutic approach

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f2124e0bff36528e9ada978918252631
https://www.hal.inserm.fr/inserm-02551254

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.